Fig. 6From: Development and validation of a new nomogram to screen for MAFLDThe clinical utility of the nomogram was evaluated by decision curves in the training dataset (A) and the validation dataset (B). The x-axis measures the threshold probability. The y-axis represents net benefits, calculated by subtracting the relative harms (false positives) from the benefits (true positives)Back to article page